Replicel Life Sciences Inc V.RP

Alternate Symbol(s): REPCF

Technology Scientific & Technical Instruments

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.

TSXV:RP - Post by User

Replicel Life Sciences Inc > Mgmt circ on sedar

<< Previous

Bullboard Posts

Next >>

Comment by Genie29jon Feb 04, 2023 12:46am

123 Views

Post# 35266491

RE:Mgmt circ on sedar

Ya that dude is a POS. There is a reason that dude was fired. Andrew is the man and will see this company through. I full heartedly think he is not only invested from a stock standpoint but from a business accumen standpoint, unlike Bukler who was just collecting a handsome paycheck.

this stock is going parabolic in 3-4 months

<< Previous

Bullboard Posts

Next >>

Understanding tax loss season and the “Santa Claus rally”